RECRUITINGOBSERVATIONAL
Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
About This Trial
The goal of this observational study is to learn how tumor tissue and blood samples from patients with sarcomas or metastases can be used to create laboratory models that help researchers study cancer behavior and test new treatments. Participants diagnosed with sarcoma or with bone or lung metastases from solid tumors will donate leftover tumor tissue and blood collected during their regular medical care. These samples will be used in the lab to build 3D models of the tumor, test drugs, and identify genetic and molecular markers. No treatments or procedures will be given as part of the study.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients (male or female) diagnosed with sarcoma or with bone or lung metastases from solid tumors
- Age between 0 and 85 years
- Availability of sufficient and adequate biological material (tumor tissue and/or blood)
- Signed willing to sign a consent form for biobanking (BIOTUM)
- Signed willing to sign a consent form for use of tissue and blood samples in this study
Who Should NOT Join This Trial:
- Diagnosis other than sarcoma or metastases from solid tumors
- Missing signed willing to sign a consent form(s)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients (male or female) diagnosed with sarcoma or with bone or lung metastases from solid tumors
* Age between 0 and 85 years
* Availability of sufficient and adequate biological material (tumor tissue and/or blood)
* Signed informed consent for biobanking (BIOTUM)
* Signed informed consent for use of tissue and blood samples in this study
Exclusion Criteria:
* Diagnosis other than sarcoma or metastases from solid tumors
* Missing signed informed consent(s)
Locations (1)
Istituto Ortopedico Rizzoli
Bologna, Italy